Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia 24Breast Neoplasms 20Lymphoma 9Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Sarcoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Leukemia, Myeloid, Acute 6Precancerous Conditions 5Multiple Myeloma 5Head and Neck Neoplasms 5Esophageal Neoplasms 5Congenital Abnormalities 5Colonic Neoplasms 5Central Nervous System Neoplasms 5Stomach Neoplasms 4Ovarian Neoplasms 4Lymphoma, Large-Cell, Anaplastic 4Colorectal Neoplasms 4Burkitt Lymphoma 4Adenocarcinoma Of Esophagus 4Wilms Tumor 3Rectal Neoplasms 3Prostatic Neoplasms 3Osteosarcoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Neuroblastoma 3

Interventions

Cyclophosphamide 38Paclitaxel 22Epirubicin 21Trastuzumab 20Docetaxel 20Doxorubicin 19Carboplatin 15Radiotherapy 13Taxes 11Filgrastim 11Neoadjuvant Therapy 9Bevacizumab 9Fluorouracil 8pembrolizumab 7Tamoxifen 7Albumin-Bound Paclitaxel 7Capecitabine 6pertuzumab 5Thiotepa 5Peripheral Blood Stem Cell Transplantation 5Lapatinib 5130-nm albumin-bound paclitaxel 5pegfilgrastim 4Granulocyte Colony-Stimulating Factor 4Cisplatin 4Chemotherapy, Adjuvant 4Biopsy 4tipifarnib 3eribulin 3Surgical Procedures, Operative 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammatory Breast Neoplasms × Microarray Analysis × Clear all
NCT00017095 2013-10-24

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
1,856 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡